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Abstract
Background: Ghrelin is a pleiotropic hormone that regulates feeding and energy balance and stimulates growth hormone release.
Ghrelin also exerts developmental and organizational effects during prenatal life.
Objectives: The aim of this study was to determine ghrelin levels in cord blood of small for gestational age (SGA) infants and its
association with GH (growth hormone) and IGF-1 levels (insulin-like growth factor-1).
Methods: Cord blood sample was obtained from 31 SGA and 25 appropriate for gestational age (AGA) infants. Acylated ghrelin, GH,
and IGF-1 levels were measured by enzyme-linked immunosorbent assay.
Results: No significant differences were observed in ghrelin and GH concentrations between SGA and AGA infants. However, IGF-1
levels were significantly lower in SGA infants. Cord blood ghrelin was negatively correlated with the infants’ birth weight (r = -0.33,
P = 0.013); on the other hand, IGF-1 level was positively correlated with birth weight (r = 0.43, P = 0.002).
Conclusions: IGF-1 has the most significant effect on intrauterine growth. Acylated ghrelin is detectable in cord blood and corre-
lated with birth weight, suggesting a role in intrauterine development, but its level is not affected by intrauterine growth retarda-
tion.
Keywords: Ghrelin, Growth Hormone (GH), IGF-1, Small for Gestational Age (SGA), Appropriate for Gestational Age (AGA),
Intrauterine Growth
1. Background
Ghrelin is a 28-amino-acid peptide that is primarily se-
creted by gastric mucosal cells and plays a key role in ap-
petite regulation and energy balance. It was discovered
through its effect on growth hormone (GH) secretion, and
thus was presumed to be effective in growth (1-3). Several
other activities have also been attributed to ghrelin (4, 5).
In addition to its effects on GH secretion, ghrelin has also
been shown to stimulate appetite and induce adiposity (6).
Small for gestational age (SGA) newborn infants
showed reduced growth during the intrauterine period,
which might have occurred because of fetal, maternal or
environmental factors. These infants have low levels of
GH after birth in response to nutritional deficiency before
birth (3). Although most of these infants may catch up
growth rapidly after birth, various patterns of weight gain
is observed in infancy, which may be related to feeding
and fasting (2, 4). There is a strong association between
very low birth weight and infant mortality, which may be
due to extreme fetal growth retardation (7).
Considering the important relationship between nu-
trition and growth and the orexigenic function of ghrelin,
this hormone seems to be closely associated with postna-
tal growth. Presence of ghrelin in umbilical cord has been
demonstrated, but few studies have measured ghrelin lev-
els in the umbilical cord of newborn infants (8, 9).
With the assumption that umbilical cord ghrelin level,
as well as GH and IGF-1 levels can indicate their levels dur-
ing intrauterine period, the aim of this study was to deter-
mine whether cord blood ghrelin, GH and IGF-1 levels are
different in SGA newborn infants compared to appropriate
for gestational age (AGA) newborn infants.
2. Methods
2.1. Participants
In this cross-sectional study, 56 newborn infants born
at Akbarabadi hospital in Tehran were included. Infants
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whose birth weight was below the 10th percentile for gesta-
tional age were defined as SGA, and those with birth weight
between 10th and 90th percentile were defined as AGA. Ac-
cording to this definition, the infants were divided into
two groups: 31 infants with SGA, and 25 with AGA. Both
groups were included consecutively and by convenience
sampling.
All the studied infants were devoid of any congenital
abnormalities, and had no history of maternal chronic dis-
eases such as diabetes, autoimmune diseases, pregnancy-
induced hypertension and pre-eclampsia. Newborns were
from third gestation or less, and the mothers did not
smoke nor had any kinds of addiction.
Demographic data, underlying conditions and 5th
minute Apgar score were recorded. The height and weight
of each infant were accurately measured and recorded in
the checklist.
The Ethics Committee of Tehran University of Medical
Sciences approved the study, and written informed con-
sent was obtained from all mothers before cord blood sam-
pling. All the procedures were in accordance with the eth-
ical standards of the responsible committee on human ex-
perimentation (institutional and national) and with the
Helsinki Declaration of 1975, as revised in 2000.
2.2. Biochemical Assays
Venous cord blood was collected immediately after
clamping the umbilical cord in EDTA tubes and kept at 4°C
before centrifugation. For ghrelin determination, PMSF
was added to the final concentration of 0.1 mg/mL as a
protease inhibitor. After centrifugation at 4°C, the sepa-
rated plasma was acidified with HCl to a final concentra-
tion of 0.05 N. All the samples were stored at 80°C until
later analysis. Acylated ghrelin was measured, using a com-
mercial ELISA kit (DRG, USA), with intra- and inter-assay CV
of 6.3% and 5.4%, respectively. Serum GH and IGF-1 were
measured by chemiluminescence sandwich assay, using
directly coated magnetic microplates (Diasorin Ltd, UK).
2.3. Statistical Analysis
The differences in variables between groups were com-
pared, using student’s t test. The chi-square test was used
to compare nominal variables between groups, and stu-
dent’s t test was used for numeric variables. The relation-
ship between different parameters was determined, using
Pearson’s correlation. All the statistical analyses were per-
formed, using SPSS Version 16 (SPSS Inc., Chicago, IL, USA). P
value < 0.05 was considered statistically significant.
3. Results
The anthropometric and biochemical characteristics
of the neonates and their mothers are presented in Table 1.
Overall, cord plasma ghrelin concentrations were 104.6±
87 pg/mL (Range 12.58 - 508.54 pg/mL). As demonstrated in
Table 1, although there was a trend towards higher ghrelin
concentration in SGA infants, no significant difference was
found between the two groups in ghrelin concentration.
Similarly, GH concentration was not statistically different
between SGA and AGA infants. IGF-1 level was significantly
lower in SGA infants compared to AGA group. No signifi-
cant differences were observed between male and female
infants in ghrelin, GH, and IGF-1 levels (Table 2).
Cord blood ghrelin concentration was negatively cor-
related with the infants’ birth weight (r = -0.33, P = 0.013).
On the other hand, IGF-1 showed a significant positive cor-
relation with birth weight (r = 0.43, P = 0.002). Never-
theless, no relationship was found between GH and birth
weight (P = 0.4). The relationship between GH, IGF-1, and
acylated ghrelin was investigated and found to be non-
significant. Mothers’ weights and their correlations with
GH, IGF-1, and ghrelin were also investigated, but no signif-
icant correlations were observed between them.
4. Discussion
The results of this study revealed that acylated ghre-
lin is correlated with birth weight, and it is slightly but
not significantly higher in SGA infants. Among the stud-
ied parameters, which are all effective in growth, IGF-1 ex-
erts the most dramatic influence on growth considering
its low concentration in SGA infants, and its strong corre-
lation with birth weight.
Ghrelin has previously been shown to be elevated in
anorexia and children with poor appetite (10) and dimin-
ished in obesity, playing a role in the regulation of energy
homeostasis; thus, it is suggested that ghrelin represents
the chronic nutritional status (11, 12). The cord blood ghre-
lin concentrations in SGA infants, compared to healthy
newborns, have been reported in a few studies (8, 12, 13).
All these studies reported that cord blood ghrelin con-
centrations of SGA infants are greater than those of AGA in-
fants, and it was suggested that ghrelin is affected by nu-
tritional status during the fetal life. However, these studies
have investigated total ghrelin levels despite the fact that
acylated form of the ghrelin is the active form of the hor-
mone, and acylation is mandatory for the biologic effects
of ghrelin on GH secretion and for binding to the recep-
tor (14). Umbilical cord acylated ghrelin concentration is
lower than maternal blood, and the placenta plays a role
in the process of acylation (15). Thus, it is plausible that
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Table 1. Characteristics of the Neonates and Their Mothersa
SGA (31) AGA (25) Total (56) P Value
Sex (M/F) 15/16 7/18 22/34 0.1
Gestational age, w 35.5± 3 37.9± 2.5 36.6± 3 0.002b
Birth weight, g 2177.6± 703.2 3247.2± 575.2 2672.7± 837.2 < 0.0001b
Gravid 1.9± 1.3 2.3± 1.1 2± 1.2 0.2
Maternal age, y 27.1± 7 29.6± 5.9 28.2± 6.6 0.1
APGAR 5 9.6± 0.6 9.9± 0.3 9.7± 0.5 0.06
Ghrelin, pg/mL 121.26± 109.4 83.9± 40.2 104.6± 87 0.08
GH, ng/mL 49.6± 40.3 54.7± 24.9 51.8± 34.2 0.58
IGF-1, ng/mL 32.2± 32 59.3± 35.9 44± 36 0.008b
Abbreviations: AGA, appropriate for gestational age; GH, growth hormone; IGF-1, insulin-like growth factor-1; SGA, small for gestational age.
aValues are expressed as mean± SD.
bSignificant difference.
Table 2. Comparison of the Levels of ghrelin, GH and IGF-1 between Female and Male
Infants
Female (34) Male (22) P Value
Ghrelin, pg/mL 109.9± 94.9 96.3± 74.7 0.57
GH, ng/mL 56.2± 32.6 45.2± 36.4 0.27
IGF-1, ng/mL 49.3± 36.9 35.9± 33.9 0.2
the acylated ghrelin changes may be different from those
of total ghrelin. Iniguez et al. investigated the serum lev-
els of ghrelin in SGA and AGA infants after fasting and in-
travenous injection of glucose and found that after fasting,
serum levels of ghrelin were not different between the SGA
and AGA groups (16).
IGF-1 is one of the main factors responsible for regu-
lating the fetal growth (17). In this study, IGF-1 levels were
found to be significantly lower in SGA infants compared
to AGA newborns. Consistent with our findings, Orbak
et al. have also demonstrated that IGF-1 levels are signifi-
cantly diminished in SGA neonates (18). This study revealed
a significant positive correlation between IGF-1 and birth
weight in contrast to ghrelin, which was negatively corre-
lated with birth weight. The levels of both of these hor-
mones seem to be altered in response to nutritional sta-
tus. Increased ghrelin level in anorexia is suggested to be
a compensatory response to undernutrition (19). On the
other hand, it has been shown that intake of proteins that
are rich in essential amino acids is positively associated
with serum IGF-1 (20) and although total calorie restriction
does not affect IGF-1 levels, protein intake is a key determi-
nant of circulating IGF-1 levels in humans (21).
Our study found that ghrelin, GH, and IGF-1 concentra-
tions were similar in male and female infants. In SGA in-
fants, these hormones were not different in the two gen-
ders, but in AGA group, GH of female infants was signif-
icantly higher than that of the male infants. Consistent
with our findings, Chanoine et al. found no significant dif-
ference between male and female infants (22).
In conclusion, these results suggest that minimal in-
crease in ghrelin levels could be the consequence of
growth restriction, but it may be caused by significant re-
duction in IGF-1. Thus, IGF-1 may be a suitable target for
managing intrauterine growth.
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